Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities

Metabolic and neurodegenerative disorders have a growing prevalence in Western countries. Available epidemiologic and neurobiological evidences support the existence of a pathophysiological link between these conditions. Glucagon-like peptide 1 (GLP-1), whose activity is reduced in insulin resistanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Mossello, Enrico, Ballini, Elena, Boncinelli, Marta, Monami, Matteo, Lonetto, Giuseppe, Mello, Anna Maria, Tarantini, Francesca, Baldasseroni, Samuele, Mannucci, Edoardo, Marchionni, Niccolò
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124026/
https://www.ncbi.nlm.nih.gov/pubmed/21747826
http://dx.doi.org/10.1155/2011/281674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124026/
https://www.ncbi.nlm.nih.gov/pubmed/21747826
http://dx.doi.org/10.1155/2011/281674

Ejemplares similares